HT-p21 |
Function Assay |
50-1250 nM |
24 h |
inhibits phosphorylation of S6 kinase (target of mTORC1) and its downstream target phospho-S6 |
|
U87vIII |
Function Assay |
0.04-2.5 μM |
24 h |
inhibits mTORC1 and mTORC2 activities |
|
U87vIII |
Function Assay |
2.5/5 μM |
12 h |
inhibits gap closing in a dose-dependent manner |
|
3T3-L1 |
Function Assay |
15 μM |
4 h |
suppresses expression of the Egr1 protein |
|
Rh30 |
Function Assay |
1 μM |
2 h |
inhibits both mTORC1-mediated phosphorylation of S6K1 and mTORC2-mediated phosphorylation of Akt |
|
HT29 |
Function Assay |
1 μM |
2 h |
inhibits both mTORC1-mediated phosphorylation of S6K1 and mTORC2-mediated phosphorylation of Akt |
|
Rh30 |
Function Assay |
1 μM |
2 h |
suppresses the basal or IGF-1-stimulated cell adhesion |
|
HT29 |
Function Assay |
1 μM |
2 h |
suppresses the basal or IGF-1-stimulated cell adhesion |
|
U87 |
Growth Inhibition Assay |
25 nM |
24 h |
increases DUSP10 knocked-down induced cell inhibition |
|
AGS |
Cell Viability Assay |
0-1000 nM |
24/48 h |
decreases cell viability in time and dose dependent manner |
|
MKN45 |
Cell Viability Assay |
0-1000 nM |
24/48 h |
decreases cell viability in time and dose dependent manner |
|
MKN28 |
Cell Viability Assay |
0-1000 nM |
24/48 h |
decreases cell viability in time and dose dependent manner |
|
KATO3 |
Cell Viability Assay |
0-1000 nM |
24/48 h |
decreases cell viability in time and dose dependent manner |
|
SGC7901 |
Cell Viability Assay |
0-1000 nM |
24/48 h |
decreases cell viability in time and dose dependent manner |
|
N87 |
Cell Viability Assay |
0-1000 nM |
24/48 h |
decreases cell viability in time and dose dependent manner |
|
HMEC |
Cell Viability Assay |
0-1000 nM |
24/48 h |
decreases cell viability in time and dose dependent manner |
|
HUVEC |
Cell Viability Assay |
0-1000 nM |
24/48 h |
decreases cell viability in time and dose dependent manner |
|
MG63 |
Function Assay |
50-1000 nM |
0.5 h |
dose dependently (50–1000 nM) inhibits phosphorylation of Akt |
|
U2OS |
Function Assay |
50-1000 nM |
0.5 h |
dose dependently (50–1000 nM) inhibits phosphorylation of Akt |
|
Saos-2 |
Function Assay |
50-1000 nM |
0.5 h |
dose dependently (50–1000 nM) inhibits phosphorylation of Akt |
|
Saos-2 |
Function Assay |
100 nM |
0.5 h |
prevents osteosarcoma cell migration |
|
MG63 |
Apoptosis Assay |
100 nM |
36 h |
promotes apoptosis |
|
U2OS |
Apoptosis Assay |
100 nM |
36 h |
promotes apoptosis |
|
Saos-2 |
Apoptosis Assay |
100 nM |
36 h |
promotes apoptosis |
|
DLD-1 |
Cell Viability Assay |
0-1000 nM |
24 h |
inhibits the growth in a dose-dependent manner |
|
Caco2 |
Cell Viability Assay |
0-1000 nM |
24 h |
inhibits the growth in a dose-dependent manner |
|
HT29 |
Cell Viability Assay |
0-1000 nM |
24 h |
inhibits the growth in a dose-dependent manner |
|
H116 |
Cell Viability Assay |
0-1000 nM |
24 h |
inhibits the growth in a dose-dependent manner |
|
Hct-8 |
Cell Viability Assay |
0-1000 nM |
24 h |
inhibits the growth in a dose-dependent manner |
|
Colo320 |
Cell Viability Assay |
0-1000 nM |
24 h |
inhibits the growth in a dose-dependent manner |
|
Sw948 |
Cell Viability Assay |
0-1000 nM |
24 h |
inhibits the growth in a dose-dependent manner |
|
Colo205 |
Cell Viability Assay |
0-1000 nM |
24 h |
inhibits the growth in a dose-dependent manner |
|
Colo320 |
Function Assay |
1 μM |
0-24 h |
abolishes the S6S235/236 but partially reduces the 4E-BP1T36/45 |
|
HT29 |
Function Assay |
1 μM |
0-24 h |
abolishes the S6S235/236 but partially reduces the 4E-BP1T36/45 |
|
Sw948 |
Function Assay |
1 μM |
0-24 h |
abolishes the S6S235/236 but partially reduces the 4E-BP1T36/45 |
|
DLD-1 |
Function Assay |
1 μM |
0-24 h |
abolishes the S6S235/236 but partially reduces the 4E-BP1T36/45 |
|
786-O |
Function Assay |
0.1/0.5 μM |
24 h |
increases E-cadherin mRNA levels dose dependently |
|
786-O |
Function Assay |
0-0.5 μM |
24 h |
results in a dose dependent increase in E-cadherin protein expression |
|
OCI-AML3 |
Apoptosis Assay |
2.5 μM |
72 h |
induces apoptosis |
|
Jurkat |
Function Assay |
100/200/400 nM |
18 h |
inhibits mTORC1-dependent S6 S235/236 phosphorylation |
|
p210 BCR-Abl |
Function Assay |
100/200/400 nM |
18 h |
inhibits mTORC1-dependent S6 S235/236 phosphorylation |
|
Jurkat |
Growth Inhibition Assay |
400nM |
24/48 h |
synergize with 17-AAG to suppress cell proliferation |
|
p210 BCR-Abl |
Growth Inhibition Assay |
400nM |
24/48 h |
synergize with 17-AAG to suppress cell proliferation |
|
8226 |
Function Assay |
100-1000 nM |
30 min |
activates ERK |
|
MM1.S |
Function Assay |
100-1000 nM |
30 min |
activates ERK |
|
8226 |
Function Assay |
0.5 μM |
30 min |
induces activation of RAF and phosphorylation of MEK |
|
MM1.S |
Function Assay |
0.5 μM |
30 min |
induces activation of RAF and phosphorylation of MEK |
|
MCF-7 |
Function Assay |
50/200/500 nM |
30 min |
dose-dependently (50–500 nM) suppresses phosphorylation of Akt |
|
T47D |
Function Assay |
50/200/500 nM |
30 min |
dose-dependently (50–500 nM) suppresses phosphorylation of Akt |
|
MDA-MB-231 |
Function Assay |
50/200/500 nM |
30 min |
dose-dependently (50–500 nM) suppresses phosphorylation of Akt |
|
Bcap-37 |
Function Assay |
50/200/500 nM |
30 min |
dose-dependently (50–500 nM) suppresses phosphorylation of Akt |
|
MCF-7 |
Apoptosis Assay |
200 nM |
36 h |
induces apoptosis |
|
MDA-MB-231 |
Apoptosis Assay |
200 nM |
36 h |
induces apoptosis |
|
Bcap-37 |
Apoptosis Assay |
200 nM |
36 h |
induces apoptosis |
|
LS174T |
Function Assay |
10/100/1000 nM |
6 h |
inhibits mTORC1 activity by the dephosphorylation of S6 ribosomal protein |
|
DLD-1 |
Function Assay |
10/100/1000 nM |
6 h |
inhibits mTORC1 activity by the dephosphorylation of S6 ribosomal protein |
|
SW480 |
Function Assay |
10/100/1000 nM |
6 h |
inhibits mTORC1 activity by the dephosphorylation of S6 ribosomal protein |
|
NIH 3T3 |
Function Assay |
2 μM |
18 h |
inhibits mTORC2 phosphorylation of Akt on Ser473 and mTORC1 phosphorylation of 4E-BP1 on Thr37/46 |
|
HCT15 |
Function Assay |
0.5/2 μM |
4 h |
prevents S6K1 phosphorylation of ribosomal protein S6 at Ser240/244 and mTORC2 phosphorylation of Akt at Ser473 |
|
SW620 |
Function Assay |
0.5/2 μM |
4 h |
blocks all three mTOR outputs |
|
PC12 |
Function Assay |
40 nM |
|
induces lysosomal biogenesis and alleviated α-SYN accumulation |
|
DND-1 |
Growth Inhibition Assay |
0.25/0.5/1 μM |
|
inhibits cell growth dose dependently |
|
TMD8 |
Growth Inhibition Assay |
0.25/0.5/1 μM |
|
inhibits cell growth dose dependently |
|
Jurkat |
Growth Inhibition Assay |
0.25/0.5/1 μM |
|
inhibits cell growth dose dependently |
|
KOPT-K1 |
Growth Inhibition Assay |
0.25/0.5/1 μM |
|
inhibits cell growth dose dependently |
|
TMD7 |
Growth Inhibition Assay |
0.25/0.5/1 μM |
|
inhibits cell growth dose dependently |
|
THP-1 |
Growth Inhibition Assay |
0.25/0.5/1 μM |
|
inhibits cell growth dose dependently |
|
HT1376 |
Growth Inhibition Assay |
|
|
IC50=1.88 ± 1.1 μM |
|
T24 |
Growth Inhibition Assay |
|
|
IC50=1.37 ± 0.4 μM |
|
UM-UC-3 |
Growth Inhibition Assay |
|
|
IC50=0.63 ±0.1 μM |
|
SW620 |
Growth Inhibition Assay |
|
|
IC50=7.8 μM |
|
SW480 |
Growth Inhibition Assay |
|
|
IC50=4.6 μM |
|
SK-CO-1 |
Growth Inhibition Assay |
|
|
IC50=4 μM |
|
LS-513 |
Growth Inhibition Assay |
|
|
IC50=3.9 μM |
|
SW1116 |
Growth Inhibition Assay |
|
|
IC50=0.84 μM |
|
LS-174T |
Growth Inhibition Assay |
|
|
IC50=0.84 μM |
|
HCT 116 |
Growth Inhibition Assay |
|
|
IC50=0.41 μM |
|
HCT 15 |
Growth Inhibition Assay |
|
|
IC50=0.3 μM |
|
COLO 205 |
Growth Inhibition Assay |
|
|
IC50=0.24 μM |
|
HT-29 |
Growth Inhibition Assay |
|
|
IC50=0.23 μM |
|
COLO 201 |
Growth Inhibition Assay |
|
|
IC50=0.23 μM |
|
Caco-2 |
Growth Inhibition Assay |
|
|
IC50=0.22 μM |
|
SW48 |
Growth Inhibition Assay |
|
|
IC50=0.09 μM |
|
SW-48 |
Growth Inhibition Assay |
|
|
IC50=0.1 μM |
|
HCT-15 |
Growth Inhibition Assay |
|
|
IC50=0.3 μM |
|
HCT 116 |
Growth Inhibition Assay |
|
|
IC50=0.6 μM |
|
SW620-R |
Growth Inhibition Assay |
|
|
IC50=1.3 μM |
|
SK-CO-1 |
Growth Inhibition Assay |
|
|
IC50=2.1 μM |
|
SW620 |
Growth Inhibition Assay |
|
|
IC50=11 μM |
|
BaF3 |
Growth Inhibition Assay |
|
|
GI50=1.449 μM |
|